Top 5 Stocks to Buy According to Ariel Investments
This article lists the top 5 stocks Ariel Investments is buying, highlighting Envista Holdings Corporation (NYSE:NVST) as one of them. Envista Holdings reported strong Q1 growth, with significant increases in core revenue, adjusted EBITDA, and EPS, and reiterated its positive full-year guidance. The company specializes in dental products and equipment and is a global medical technology firm spun off from Danaher Corporation.
Is Envista Holdings Corp (NVST) Overvalued After 3.1% Rally? GF
Envista Holdings Corp (NVST) saw its shares rally 3.1% to $27.17 on July 1, 2026, but GuruFocus' GF Value™ indicates the stock is currently overvalued by 13.8% at $23.87. Despite a strong GF Score™ of 80/100 suggesting solid fundamentals, its P/E ratio of 66.3x is significantly above its historical median, and a lack of insider transactions in the last three months raises concerns about insider confidence. Investors are advised to exercise caution due to the premium valuation.
Envista Holdings Corp. Financial Disclosures & Filings
This article provides a comprehensive list of Envista Holdings Corp.'s financial disclosures and regulatory filings, organized by year. It details earnings calls, annual general meetings, and conference presentations, offering insights into the company's performance, strategy, and investment decisions. Key highlights include financial growth figures, guidance updates, and strategic initiatives.
Envista Holdings Corp. Financial Disclosures & SEC Filings
This article provides a compilation of Envista Holdings Corporation's financial disclosures and SEC filings, including earnings reports, annual general meeting summaries, and conference presentations, spanning from 2023 to 2026. It highlights key financial performance metrics, operational updates, and strategic announcements made by the company.
The John Rogers Contrarian Playbook: How Envista, MSG Entertainment, and Smucker Stack Up for Retirement Investors
This article analyzes three companies—Envista, MSG Entertainment, and J.M. Smucker—through the lens of John Rogers's contrarian investing philosophy, specifically for retirement portfolios. It evaluates each stock based on income reliability, business predictability, and volatility, concluding that only J.M. Smucker is suitable for retirees due to its dividend, low beta, and consumer staples nature. Envista and MSG Entertainment, despite having contrarian appeal, lack dividends and exhibit higher volatility, making them less ideal for income-focused retirement investors.
Envista Holdings Corp. Actuals & Estimates (DUS:0HV)
This article provides an overview of Envista Holdings Corp. (DUS:0HV), including its financial actuals and estimates as presented on TradingView. It covers analyst forecasts for the stock's price, historical high and low points, upcoming earnings reports, and key financial metrics like earnings per share, revenue, net income, and EBITDA. The article also touches on employee numbers and dividend policy.
NVST Financials: Revenue Breakdown, Margins & Competitor Comparison
This article analyzes Envista Holdings Corp's (NVST) financial performance, highlighting its revenue streams, profitability, and competitive standing. The company generates most of its revenue from Specialty Products & Technologies, and it maintains a gross margin of 55.73%. A comparison with competitors VCYT and CELC positions NVST within the Medical Equipment, Supplies & Distribution industry.
Envista Holdings Corp. Actuals & Estimates (NYSE:NVST)
This article provides an overview of Envista Holdings Corporation (NYSE: NVST) stock, including its current price, historical performance, analyst forecasts, and financial data. It details recent earnings, revenue, market capitalization, and employee count, while also addressing frequently asked questions about investing in the company.
Price to book forward of Envista Holdings Corp. – DUS:0HV
This article focuses on the "Price to book forward" financial metric for Envista Holdings Corp. (DUS:0HV). It is presented within the context of TradingView's financial data offerings, indicating its relevance to investors and financial analysis for the company. The content itself provides a value for this specific metric and specifies the period over which it was measured.
Enterprise value to revenue forward of Envista Holdings Corp. – DUS:0HV
This article focuses on the enterprise value to revenue forward metric for Envista Holdings Corp. (DUS:0HV). It is presented as a financial data point available on TradingView, covering the company's performance on the Dusseldorf Stock Exchange. The content is primarily a data placeholder within a financial platform's interface.
Envista Holdings Corp (NVST) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Envista Holdings Corp (NVST), covering its price momentum score of 8.95 and its ranking within the Healthcare Equipment & Supplies industry. It details key support and resistance levels, making it suitable for range-bound swing trading, and offers a breakdown of various technical indicators and moving averages, suggesting a "Buy" signal based on current analysis.
Net current asset value per share of Envista Holdings Corp. – FWB:0HV
This article provides financial information for Envista Holdings Corp. (FWB:0HV) on the Frankfurt Stock Exchange, specifically focusing on its net current asset value per share. The content is presented as a financial data overview without specific numerical values, indicating market closure and no recent trades.
Is Envista Holdings (NVST) Becoming an Institutional Favorite Without a Fully Transparent Valuation Story?
Envista Holdings (NVST) is experiencing increasing institutional ownership and positive price momentum despite a high P/E multiple. The article highlights that Envista's valuation story lacks full transparency beyond its P/E ratio, making its growing institutional support a point of interest. The company's investment narrative centers on digital dentistry, emerging markets, and margin improvement, with projections for significant revenue and earnings growth by 2029.
Is Envista Holdings (NVST) Becoming an Institutional Favorite Without a Fully Transparent Valuation Story?
Envista Holdings (NVST) is experiencing increasing institutional ownership, despite a high P/E multiple and limited transparent valuation metrics beyond this ratio. The company's investment narrative centers on digital dentistry, emerging market expansion, and margin improvement. While institutional buying indicates confidence, some analysts remain cautious about future revenue and earnings due to potential regulatory price controls.
Envista Holdings Corp (NVST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Envista Holdings Corp (NVST), focusing on its regional revenue contributions. Specifically, it highlights that the United States accounts for 47.12% ($1.28 billion) of the company's revenue, while "All Other" regions contribute 45.74% ($1.24 billion) and China contributes 7.15% ($194.40 million). The financial figures are updated as of April 6, with further detailed data for business segments not yet disclosed.
Envista Holdings Corp (NVST) Financial Health: Profitability & Balance Sheet Analysis
Envista Holdings Corp (NVST) has a robust financial score of 8.13, ranking 41 out of 204 in the Healthcare Equipment & Supplies industry. The company's latest quarterly revenue increased by 14.36% year-over-year to 705.50M, with net profit rising by 115.00% year-over-year. Its operating efficiency is noted as average, with details on Quality of Earnings, Growth Potential, and Shareholder Returns also highlighted.
Envista Holdings Corp (NVST) Valuation: PE, PB & Fair Value Analysis
This article analyzes the valuation of Envista Holdings Corp (NVST), highlighting its current valuation score of 6.53 and ranking within the Healthcare Equipment & Supplies industry. It details the company's P/E ratio, noting its significant deviation from recent highs and lows. The analysis also mentions the unavailability of recent P/B, P/S, and P/CF data yet.
Envista Holdings Corp (NVST) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Envista Holdings Corp (NVST), highlighting its current earnings forecast score of 7.60 and an average price target of $22.00. Based on 15 analysts, the stock has a "Buy" trend. The report also details expected revenue for the next quarter ($714.64M) and anticipated EPS ($0.33).
Envista Holdings Corp (NVST) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides historical dividend and stock split information for Envista Holdings Corp (NVST). It states that no dividends have been distributed over the past five years and no stock splits have been recorded. The article also presents current stock data for NVST, including its market cap and P/E ratio.
Envista Holdings Corp (NVST) Institutional Confidence
Envista Holdings Corp (NVST) has a strong institutional confidence score of 10.00, ranking first in its industry. Institutional shareholding increased by 7.12% quarter-over-quarter, with John Rogers being the largest institutional shareholder despite a slight reduction in his holdings. The article details major institutional investors and their recent activity in NVST.
NVST Maintained by Barclays -- Price Target Lowered to $32.00
Barclays analyst Glen Santangelo maintained an Overweight rating on Envista Holdings (NVST) but lowered the price target from $34.00 to $32.00. GuruFocus indicates NVST is slightly overvalued with a GF Value of $23.84 against a current price of $23.99, despite having strong fundamentals and a GF Score of 81/100. The adjustment reflects a cautious outlook, possibly due to short-term challenges, without recent insider trading activity.
Envista (NYSE: NVST) appoints Coree Thomas chief accounting officer
Envista Holdings Corporation (NYSE: NVST) announced that Coree Thomas has been appointed Vice President and Chief Accounting Officer, effective August 6, 2026. This appointment follows the retirement of the current Chief Accounting Officer, Faez Kaabi, who will resign on the same date. Thomas, aged 48, joined Envista in February 2023 and previously held senior finance roles at other major companies.
NVST - Envista Holdings Corp Stock Price and Quote
Envista Holdings Corp (NVST) is trading at $27.63, reflecting a 1.69% increase. The article provides detailed financial data including market capitalization, income, sales, P/E ratios, and insider transaction information. It also lists recent analyst ratings and news headlines related to the company's performance, earnings calls, and product launches.
Envista (NVST) CEO has 12,811 shares withheld for RSU tax obligations
Envista Holdings Corp CEO Paul A. Keel reported a routine tax-related share disposition where 12,811 shares of common stock were withheld to satisfy tax obligations upon the vesting of stock-settled restricted stock units. The shares were valued at $23.43 each. Following this non-market transaction, Keel directly holds 371,574 shares of Envista common stock.
Envista (NYSE: NVST) director awarded 9,330 RSUs vesting in one year
Envista Holdings Corp director Christine A. Tsingos was awarded 9,330 Restricted Stock Units (RSUs) as compensation for her board service, which will vest one year from the grant date of May 19, 2026. Following this grant, Tsingos directly holds 59,930 shares of Envista common stock. This transaction is considered a neutral event as it represents an equity grant rather than an open market buy or sell.
EDGAR Filing Documents for 0001757073-25-000007
This document is an EDGAR filing for Envista Holdings Corp (CIK: 0001757073), an annual report (Form 10-K) filed on February 13, 2025, for the period ending December 31, 2024. It includes various exhibits such as stock option agreements, insider trading policy, and financial statements in iXBRL and other formats, providing comprehensive details about the company's financial status and corporate governance.
Director Vivek Jain receives 9,330 Envista (NVST) RSUs as annual equity grant
Envista Holdings Corp director Vivek Jain was granted 9,330 Restricted Stock Units (RSUs) as annual compensation for his board service. These RSUs will vest one year from the grant date, and upon vesting, each RSU converts into one share of Envista common stock. Following this award, Jain's direct holdings, including the RSUs, now total 52,945 shares.
Envista (NYSE: NVST) director granted 9,330 RSUs vesting in 1 year
Envista Holdings Corp (NYSE: NVST) director James Andrew Pierce was granted 9,330 Restricted Stock Units (RSUs) as part of his compensation for board service. These RSUs will vest one year from the grant date and are payable in Envista common stock on a one-to-one basis. Following this transaction, Pierce's direct holdings in the company now total 18,485 shares.
Envista Holdings shareholders elect directors and approve proposals at annual meeting
Envista Holdings Corporation (NYSE:NVST) held its 2026 Annual Meeting of Stockholders, where shareholders elected all eight director nominees for one-year terms. They also ratified Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026 and approved the compensation for named executive officers. The company adopted a policy to hold annual advisory votes on executive compensation, following shareholder preference.
Envista (NVST) director Huennekens receives 12,585 RSUs in equity grant
Envista Holdings Corp (NVST) director R. Scott Huennekens has been granted 12,585 Restricted Stock Units (RSUs) as part of his annual equity compensation for board service. These RSUs, granted at no cash cost, will vest on the first anniversary of the grant date and convert into one share of common stock per RSU. Following this grant, Huennekens directly holds 82,105 shares of Envista common stock, aligning his interests with shareholders.
Envista (NYSE: NVST) investors approve board, auditor and annual say-on-pay
Envista Holdings Corporation (NYSE: NVST) stockholders approved all key proposals at their 2026 Annual Meeting. They re-elected eight directors for one-year terms, ratified Ernst & Young LLP as the independent auditor for 2026, and approved the company's named executive officer compensation on an advisory basis. Stockholders also overwhelmingly supported holding future advisory say-on-pay votes annually.
Aristotle Small Cap Equity Fund Picked Envista Holdings (NVST) Citing Varied Growth Signals
Aristotle Small Cap Equity Fund has added Envista Holdings Corporation (NVST) to its portfolio, as detailed in its Q1 2026 investor letter. The fund believes Envista, a dental products company, offers exposure to a growing dental market with potential for margin recovery and an attractive valuation. Despite Envista's presence in 36 hedge fund portfolios, the fund suggests some AI stocks might offer higher and quicker returns.
Envista (NVST) director Wendy Carruthers receives 9,330 RSU equity grant
Envista Holdings Corp (NVST) director Wendy Carruthers was granted 9,330 Restricted Stock Units (RSUs) on May 19, 2026, as part of her annual equity compensation for board service. These RSUs will vest on the first anniversary of the grant date and are payable in Envista common stock. Following this transaction, Carruthers directly holds a total of 59,940 shares of Envista common stock.
Envista (NYSE: NVST) director Kieran Gallahue receives 9,330-share RSU award
Envista (NYSE: NVST) director Kieran Gallahue was granted 9,330 Restricted Stock Units (RSUs) as board compensation on May 19, 2026. These RSUs, awarded at no cash purchase price, will vest on the first anniversary of the grant date and are payable in Envista common stock on a one-to-one basis. Following this award, Gallahue's direct holdings in Envista common stock, including the unvested RSUs, total 54,010 shares.
NVST Stock Price Prediction 2025-2026 | Envista Holdings Corp Forecast
24/7 Wall St. rates Envista Holdings Corp (NVST) as a BUY with a 12-month target price of $33.90, suggesting a 46.44% upside from its current price of $23.15. The analysis includes optimistic and conservative scenarios, projecting NVST could reach $37.30 and $28.16 respectively. Long-term forecasts for 2030 indicate an average price of $53.78, with analysts largely favorable towards the stock, highlighting strong earnings growth and sector tailwinds as key catalysts.
Envista Holdings Corp (NYSE:NVST) Q1 2026 Earnings Call Transcript
Envista Holdings Corp (NYSE: NVST) reported a strong start to 2026 with Q1 core growth of 9.5%, exceeding earnings expectations with an EPS of $0.36 against an expected $0.31. The company saw broad-based performance across its portfolio, including double-digit growth in Ortho consumables and diagnostics, while reaffirming its full-year 2026 guidance and authorizing an additional $300 million for share repurchases. Despite macro uncertainties and potential VBP impacts in China, Envista highlighted improved execution, operational discipline, and strategic investments in new products and an accretive tuck-in acquisition (Versah) as drivers for its continued momentum.
Envista Holdings Corporation Common Stock (NY: NVST
This compilation provides recent news and financial updates for Envista Holdings Corporation (NYSE:NVST). It features headlines covering Q1 2026 earnings results, analyst insights, product launches, and broader healthcare industry analysis. The articles highlight Envista's financial performance, market reactions, and related stock movements.
Envista Q1 2026 slides: 9.5% core growth drives 50% EPS surge
Envista Holdings Corporation reported strong Q1 2026 results with 9.5% core sales growth and a 50% year-over-year increase in adjusted earnings per share, despite a 7.25% stock decline in after-hours trading. The company affirmed its full-year 2026 guidance, highlighting broad-based momentum across its dental product segments, strategic acquisitions, and new product launches as key growth drivers. Envista also authorized an additional $300 million for share repurchases, signaling confidence in its financial outlook.
Earnings call transcript: Envista Holdings beats Q1 2026 forecasts but stock dips
Envista Holdings (NVST) reported strong Q1 2026 financial results, exceeding EPS and revenue forecasts, but its stock declined by 7.25% in after-hours trading due to broader market conditions and future guidance. The company achieved 9.5% year-over-year core revenue growth and a 25% increase in adjusted EBITDA, driven by new product launches and strategic acquisitions. Envista reaffirmed its full-year 2026 guidance and authorized an additional $300 million share repurchase program, demonstrating confidence despite ongoing macro volatility and potential supply chain risks.
Morgan Stanley and Atlanta Capital report holdings in Envista (NYSE: NVST)
Morgan Stanley and Atlanta Capital Management have filed amended Schedule 13G/A forms reporting their institutional holdings in Envista Holdings Corp (NYSE: NVST). Both firms indicate they have ceased to be beneficial owners of more than five percent of the class of securities as of the filing date, May 11, 2026. Morgan Stanley reports beneficial ownership of 4.4%, while Atlanta Capital Management reports 3.7%.
NVST SEC Filings - Envista Holdings Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors and traders to access Envista Holdings Corporation (NVST) SEC filings. It details the types of documents available, such as 10-K annual reports, 10-Q quarterly reports, and 8-K material event forms, along with their content and significance. The platform offers AI-powered summaries, impact scoring, and sentiment analysis for these regulatory documents.
Envista Down Nearly 10%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Envista Holdings Corporation's stock is experiencing a significant drop of nearly 10%, putting it on track for its largest percentage decrease since March 2020. This downturn follows previous market actions, including a recent rally and a three-day losing streak that saw 7.1% wiped off its market value. The stock is trading below its 50-day moving average, signaling increased bearish sentiment.
Earnings call transcript: Envista Holdings beats Q1 2026 forecasts, stock rises
Envista Holdings Corp. (NVST) reported strong Q1 2026 financial results, surpassing analyst expectations with an EPS of $0.36 and revenue of $706 million. Following the announcement, the stock rose by 1.57% in after-hours trading, reflecting positive investor sentiment driven by robust growth across all business segments and new product launches. The company reaffirmed its full-year 2026 guidance and authorized an additional $300 million for share repurchases, balancing organic growth investments with shareholder returns.
Envista Q1 2026 slides: 9.5% core growth drives 50% earnings jump
Envista Holdings Corp. reported robust Q1 2026 results with adjusted earnings per share of $0.36, a 50% year-over-year increase, and revenue of $706 million, exceeding analyst expectations. The company achieved 9.5% core sales growth, driven by strong performance across both Specialty Products & Technologies and Equipment & Consumables segments. Envista also reaffirmed its full-year 2026 guidance and authorized an additional $300 million for share repurchases, highlighting confidence in its strategic initiatives and operational excellence.
Envista: Q1 Earnings Snapshot
Envista Holdings Corp. reported strong first-quarter earnings, with net income totaling $38.7 million. The company exceeded Wall Street's expectations with adjusted earnings of 36 cents per share on revenue of $705.5 million. Envista also provided a full-year earnings forecast in the range of $1.35 to $1.45 per share.
Envista (NYSE: NVST) posts Q1 2026 growth, boosts margins and buybacks
Envista Holdings Corporation (NYSE: NVST) reported strong first-quarter 2026 results, with sales up 14.4% year-on-year to $705.5 million and adjusted diluted EPS increasing 50% to $0.36. The company also improved its adjusted EBITDA margin to 14.0% and authorized an additional $300 million stock repurchase program. Envista reaffirmed its full-year 2026 guidance, demonstrating confidence in continued growth and profitability despite a negative operating cash flow in Q1.
Envista (NYSE:NVST) Posts Better-Than-Expected Sales In Q1 CY2026
Envista Holdings (NYSE:NVST) exceeded Wall Street's revenue and adjusted EPS expectations in Q1 CY2026, with sales increasing 14.4% year-on-year to $705.5 million and adjusted EPS reaching $0.36. Despite a solid quarter, including reaffirmed full-year Adjusted EPS guidance, investors reacted by trading shares down 1.1% immediately after the report. The company's long-term revenue growth has been mediocre, and its adjusted operating margin has decreased over the last five years, indicating challenges in profitability management.
Envista Reports First Quarter 2026 Results
Envista Holdings Corporation (NYSE: NVST) announced strong first-quarter 2026 results, reporting $706 million in sales with 9.5% core sales growth, and significant increases in adjusted EBITDA (+25%) and adjusted diluted EPS (+50%). The company highlighted broad-based growth across all major businesses, driven by customer engagement and new product commercialization. Envista reaffirmed its full-year 2026 guidance and authorized an incremental $300 million share repurchase program.
Envista earnings in focus as dental leader tests momentum
Envista Holdings Corp. is poised to release its first-quarter results, with analysts anticipating earnings per share of $0.31 and revenue of $680.52 million. Investors will be observing whether the company can sustain market share gains, particularly in specialty products and equipment, and continue its margin expansion efforts. Envista's performance will also be assessed against its full-year guidance and its ability to leverage digital dentistry trends, especially after a strong fourth-quarter showing in 2025.
Envista (NVST) Q1 Earnings: What To Expect
Envista Holdings (NVST) is set to report its Q1 earnings this Wednesday. The market anticipates a 9.5% year-on-year revenue growth, a turnaround from last year's decrease, following a strong previous quarter where Envista beat revenue and EPS estimates. Investors are looking for continued positive performance, especially given mixed results from peers like Align Technology and Intuitive Surgical.
